300435.SZ
Hangzhou Zhongtai Cryogenic Technology Corporation [300435.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
300435.SZ Stock Summary
Top 10 Correlated ETFs
300435.SZ
Top 10 Correlated Stocks
300435.SZ
In the News
300435.SZ Financial details
Company Rating
Strong Buy
Market Cap
5.22B
Income
285.39M
Revenue
3.32B
Book val./share
7.47
Cash/share
3.56
Dividend
0.1
Dividend %
0.73%
Employees
1.11K
Optionable
No
Shortable
Yes
Earnings
22 Apr 2021
P/E
18.61
Forward P/E
-
PEG
-17.28
P/S
1.57
P/B
1.83
P/C
3.85
P/FCF
-18.63
Quick Ratio
0.77
Current Ratio
1.49
Debt / Equity
0.29
LT Debt / Equity
0.04
-
-
EPS (TTM)
0.58
EPS next Y
-
EPS next Q
-
EPS this Y
12.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
22.01%
Revenue last 5Y
40.5%
Revenue Q/Q
9.82%
EPS Q/Q
-
-
-
-
-
SMA20
-3.02%
SMA50
-9.07%
SMA100
3.67%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
10%
ROC
0.11%
Gross Margin
17%
Oper. Margin
11%
Profit Margin
9%
Payout
23%
Shs Outstand
381.38M
Shs Float
171.4M
-
-
-
-
Target Price
-
52W Range
12.96-19.66
52W High
-27.95%
52W Low
+14.08%
RSI
31.97
Rel Volume
0.68
Avg Volume
5.42M
Volume
3.68M
Perf Week
-6.3%
Perf Month
-2.35%
Perf Quarter
-5.39%
Perf Half Y
-7.12%
-
-
-
-
Beta
0.606267
-
-
Volatility
0.3%, 0.42%
Prev Close
0.37%
Price
13.69
Change
0.44%
300435.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 2.37 | 3.87 | 5.24 | 6.38 | 8.55 | |
| Net income per share | 0.27 | 0.29 | 0.52 | 0.65 | 0.73 | |
| Operating cash flow per share | 0.41 | 0.49 | 1.11 | 0.83 | 0.76 | |
| Free cash flow per share | 0.36 | 0.46 | 0.36 | 0.27 | 0.07 | |
| Cash per share | 1.04 | 1.37 | 1.98 | 2.51 | 3.37 | |
| Book value per share | 3.25 | 7.89 | 6.08 | 6.68 | 7.4 | |
| Tangible book value per share | 3.12 | 5.09 | 3.95 | 4.59 | 5.35 | |
| Share holders equity per share | 3.25 | 7.89 | 6.08 | 6.68 | 7.4 | |
| Interest debt per share | 0.63 | 0.62 | 0.7 | 0.87 | 1.8 | |
| Market cap | 2.42B | 2.87B | 4.89B | 8.83B | 5.08B | |
| Enterprise value | 2.31B | 2.79B | 4.4B | 8.3B | 4.46B | |
| P/E ratio | 35.75 | 37.1 | 24.92 | 36 | 18.27 | |
| Price to sales ratio | 4.07 | 2.78 | 2.47 | 3.67 | 1.56 | |
| POCF ratio | 23.57 | 22 | 11.65 | 28.04 | 17.62 | |
| PFCF ratio | 27.15 | 23.55 | 35.69 | 87.39 | 184.77 | |
| P/B Ratio | 2.97 | 1.36 | 2.13 | 3.5 | 1.8 | |
| PTB ratio | 2.97 | 1.36 | 2.13 | 3.5 | 1.8 | |
| EV to sales | 3.88 | 2.69 | 2.22 | 3.45 | 1.37 | |
| Enterprise value over EBITDA | 24.68 | 17.26 | 12.5 | 20.21 | 8.91 | |
| EV to operating cash flow | 22.49 | 21.34 | 10.48 | 26.36 | 15.47 | |
| EV to free cash flow | 25.92 | 22.84 | 32.11 | 82.14 | 162.22 | |
| Earnings yield | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 | |
| Free cash flow yield | 0.04 | 0.04 | 0.03 | 0.01 | 0.01 | |
| Debt to equity | 0.18 | 0.07 | 0.11 | 0.12 | 0.24 | |
| Debt to assets | 0.11 | 0.05 | 0.07 | 0.08 | 0.14 | |
| Net debt to EBITDA | -1.18 | -0.54 | -1.4 | -1.29 | -1.24 | |
| Current ratio | 1.85 | 1.97 | 1.78 | 1.56 | 1.49 | |
| Interest coverage | 7.84 | 14.21 | 29.09 | 24.97 | 15.97 | |
| Income quality | 1.52 | 1.69 | 2.17 | 1.28 | 1.04 | |
| Dividend Yield | 0.02 | 0.01 | 0.01 | 0 | 0.01 | |
| Payout ratio | 0.84 | 0.29 | 0.14 | 0.18 | 0.18 | |
| Sales general and administrative to revenue | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | |
| Research and developement to revenue | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.02 | 0.26 | 0.23 | 0.2 | 0.17 | |
| Capex to operating cash flow | -0.13 | -0.07 | -0.67 | -0.68 | -0.9 | |
| Capex to revenue | -0.02 | -0.01 | -0.14 | -0.09 | -0.08 | |
| Capex to depreciation | -1.23 | -0.37 | -4.36 | -2.65 | -3.04 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 4.44 | 7.18 | 8.44 | 9.88 | 11.03 | |
| ROIC | 0.07 | 0.05 | 0.12 | 0.13 | 0.16 | |
| Return on tangible assets | 0.05 | 0.04 | 0.07 | 0.08 | 0.07 | |
| Graham Net | -0.96 | -1.19 | -0.79 | -0.8 | -1.15 | |
| Working capital | 491.13M | 724.15M | 778.6M | 725.2M | 834M | |
| Tangible asset value | 781.63M | 1.36B | 1.49B | 1.73B | 2.04B | |
| Net current asset value | 464.71M | 697.34M | 627.45M | 637.38M | 665.58M | |
| Invested capital | 0.18 | 0.07 | 0.11 | 0.12 | 0.24 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 150.62M | 209.5M | 273.23M | 314.73M | 363.24M | |
| Average inventory | 167.64M | 190.93M | 192.01M | 247.56M | 282.5M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 138.59 | 113.68 | 68.98 | 62.41 | 53.12 | |
| Days of inventory on hand | 170.88 | 79.03 | 48.92 | 53.37 | 37.82 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.63 | 3.21 | 5.29 | 5.85 | 6.87 | |
| Inventory turnover | 2.14 | 4.62 | 7.46 | 6.84 | 9.65 | |
| ROE | 0.08 | 0.04 | 0.09 | 0.1 | 0.1 | |
| Capex per share | -0.05 | -0.03 | -0.75 | -0.57 | -0.68 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 2.27 | 1.84 | 2.01 | 0 | 2.45 | |
| Net income per share | 0.16 | 0.2 | 0.2 | 0 | 0.18 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | -0.13 | -0.15 | -0.18 | 0 | -0.18 | |
| Cash per share | 2.66 | 3.82 | 3.63 | 0 | 3.56 | |
| Book value per share | 6.64 | 6.78 | 7.04 | 0 | 7.47 | |
| Tangible book value per share | 4.63 | 4.78 | 5.05 | 0 | 5.46 | |
| Share holders equity per share | 6.64 | 6.78 | 7.04 | 0 | 7.47 | |
| Interest debt per share | 1.12 | 2.13 | 1.95 | 0 | 2.15 | |
| Market cap | 6.66B | 5.96B | 5.23B | 0 | 5.95B | |
| Enterprise value | 6.1B | 5.29B | 4.56B | -620.04M | 5.39B | |
| P/E ratio | 26.67 | 19.55 | 16.57 | 0 | 21.29 | |
| Price to sales ratio | 7.51 | 8.29 | 6.66 | 0 | 6.25 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | -129.76 | -101.67 | -72.77 | 0 | -83.93 | |
| P/B Ratio | 2.57 | 2.25 | 1.9 | 0 | 2.05 | |
| PTB ratio | 2.57 | 2.25 | 1.9 | 0 | 2.05 | |
| EV to sales | 6.89 | 7.37 | 5.82 | -0.72 | 5.67 | |
| Enterprise value over EBITDA | 72.98 | 49.25 | 34.79 | -6.7 | 63.26 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | -119 | -90.34 | -63.55 | 7.85 | -76.1 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0 | 0.01 | |
| Free cash flow yield | -0.01 | -0.01 | -0.01 | 0 | -0.01 | |
| Debt to equity | 0.17 | 0.31 | 0.27 | 0.24 | 0.29 | |
| Debt to assets | 0.11 | 0.18 | 0.16 | 0.14 | 0.17 | |
| Net debt to EBITDA | -6.6 | -6.18 | -5.05 | -6.7 | -6.51 | |
| Current ratio | 1.64 | 1.51 | 1.58 | 1.49 | 1.49 | |
| Interest coverage | 25.94 | 16.94 | 13.85 | 12.37 | 13.24 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
| Payout ratio | 0.06 | 0.46 | 0.23 | 0.1 | 0.07 | |
| Sales general and administrative to revenue | 0.02 | 0 | 0.06 | -0.02 | 0.02 | |
| Research and developement to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.19 | 0.17 | 0.17 | 0.17 | 0.16 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | -0.06 | -0.08 | -0.09 | -0.09 | -0.07 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 4.89 | 5.46 | 5.66 | 0 | 5.5 | |
| ROIC | 0.03 | 0.06 | 0.06 | 0.03 | 0.04 | |
| Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Graham Net | -0.76 | -0.76 | -0.74 | 0 | -1.1 | |
| Working capital | 859.35M | 878.6M | 953.9M | 834M | 883.63M | |
| Tangible asset value | 1.81B | 1.86B | 1.97B | 2.04B | 2.12B | |
| Net current asset value | 722.35M | 708.03M | 783.44M | 665.58M | 716.25M | |
| Invested capital | 0.17 | 0.31 | 0.27 | 0.24 | 0.29 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 285.12M | 317.16M | 363.41M | 368.05M | |
| Average inventory | 0 | 258.85M | 235.56M | 256.39M | 290.3M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 31.59 | 46.34 | 49.37 | 47.88 | 37.25 | |
| Days of inventory on hand | 32.73 | 36.72 | 34.46 | 34.08 | 32.66 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.85 | 1.94 | 1.82 | 1.88 | 2.42 | |
| Inventory turnover | 2.75 | 2.45 | 2.61 | 2.64 | 2.76 | |
| ROE | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Capex per share | -0.13 | -0.15 | -0.18 | 0 | -0.18 |
300435.SZ Frequently Asked Questions
What is Hangzhou Zhongtai Cryogenic Technology Corporation stock symbol ?
Hangzhou Zhongtai Cryogenic Technology Corporation is a CN stock and trading under the symbol 300435.SZ
What is Hangzhou Zhongtai Cryogenic Technology Corporation stock quote today ?
Hangzhou Zhongtai Cryogenic Technology Corporation stock price is $13.69 today.
Is Hangzhou Zhongtai Cryogenic Technology Corporation stock public?
Yes, Hangzhou Zhongtai Cryogenic Technology Corporation is a publicly traded company.
Company Profile
- Volume Average 5.42M
- Market Capitalization 5.22B
- Employee 1.11K
- CEO Mr. Youhu Zhang
- Headquarters Hangzhou,CN
- IPO Date 2015-03-26
-
Website
https://www.zhongtaihangzhou.com 
Hangzhou Zhongtai Cryogenic Technology Corporation develops, designs, manufactures, and sells cryogenic equipment in China. The company offers packaged units, such as cryogenic liquefaction plants for liquefied natural gas; cryogenic purification plants for liquid nitrogen washing devices; and cryogenic separation plants for H2-CO separation units. It also provides cold box products that include liquefied natural gas, liquid nitrogen washing, ethylene, air separation unit, propane dehydrogenation propylene, methanol to olefins/methanol to propylene, and carbon monoxide cold boxes. In addition, the company offers plate-fin heat exchangers, such as aluminum plate-fin heat exchangers and ethylene column overhead condensers/plate-fin vessels. It serves customers in the energy, chemical, metallurgy, electric power, liquefied natural gas, and modern coal chemical industries. It also exports its products to the United State, Europe, India, etc. Hangzhou Zhongtai Cryogenic Technology Corporation was founded in 2006 and is based in Hangzhou, China.
